Tag

Prevent Ascvd

All articles tagged with #prevent ascvd

AHA's 2026 Dyslipidemia Guideline: Start Screening Early for Lifelong Heart Health
health26 days ago

AHA's 2026 Dyslipidemia Guideline: Start Screening Early for Lifelong Heart Health

The AHA and ACC released the 2026 Guideline on the Management of Dyslipidemia, shifting from older risk scores to the PREVENT-ASCVD calculator to estimate 10- and 30-year ASCVD risk and emphasize lifelong heart-risk reduction through earlier screening and personalized therapy. It highlights measuring biomarkers like Lp(a) and ApoB, using coronary artery calcium scoring, and keeping statins as first-line therapy with new lipid-lowering options, advocating for earlier intervention—especially in younger adults—to reduce future heart attack and stroke risk.

2026 Lipid Guidelines Use PREVENT Scores to Tailor Therapy
health27 days ago

2026 Lipid Guidelines Use PREVENT Scores to Tailor Therapy

The 2026 American dyslipidemia guideline endorses PREVENT-ASCVD risk equations to guide primary prevention therapy and suggests considering lipid-lowering treatment for adults at intermediate risk based on a 10-year PREVENT-ASCVD risk, with additional considerations for borderline risk and for patients with moderate subclinical atherosclerosis, aiming to lower LDL cholesterol.

2026 ACC/AHA Dyslipidemia Guideline Emphasizes Early Intervention and PREVENT-ASCVD
health28 days ago

2026 ACC/AHA Dyslipidemia Guideline Emphasizes Early Intervention and PREVENT-ASCVD

The 2026 ACC/AHA Guideline on Dyslipidemia consolidates evidence-based recommendations, retires the 2018 cholesterol guideline, and stresses earlier lifestyle measures from childhood along with earlier pharmacotherapy for familial hypercholesterolemia and high LDL-C. It also adopts the PREVENT-ASCVD risk equations to guide lipid-lowering therapy in adults aged 30–79, aiming to improve ASCVD prevention.

New ACC/AHA Dyslipidemia Guideline Promotes Early Lifestyle Action and Risk-Tailored Therapy
heart-news28 days ago

New ACC/AHA Dyslipidemia Guideline Promotes Early Lifestyle Action and Risk-Tailored Therapy

The ACC, AHA and partners released an updated dyslipidemia guideline that emphasizes earlier lifestyle changes, lower LDL-C targets based on individual risk, and earlier use of lipid-lowering therapies; it introduces the PREVENT-ASCVD risk calculator for primary prevention, expands testing for lipids including lipoprotein(a) and apolipoprotein B, and recommends selective use of coronary calcium scoring to guide treatment decisions, with guidance extending to pediatric screening and different populations to reduce lifetime ASCVD risk.